Previous research established LINC00152 overexpression in HCC tissues compared to healthy controls and demonstrated its role as an independent prognostic factor associated with poorer patient survival35,36, suggesting its potential as a therapeutic target for HCC37. This evidence concerns the gene CYTOR and hepatocellular carcinoma.